Catalent president and CEO Alessandro Maselli said on Monday he will stay on as the contract drugmaker's chief after it is ...

Alessandro Maselli will remain president and CEO of Catalent (NYSE:CTLT) after its acquisition by Novo Holdings, according to ...

Catalent (CTLT) issued the following open letter to customers: “I want to correct a few key inaccuracies that have been reported in the ...

Catalent, a leading contract drug manufacturer, issued an open letter Monday to reassure customers that a proposed $16.5 ...

India's biggest group of retail distributors has asked the antitrust authority to investigate three quick commerce companies ...

Openbank, which has operated in parts of Europe for years, should help the Spanish bank to fund its U.S. auto lending ...

Hospitals across India - as in much of the world - are often understaffed and doctors and nurses overworked resulting in ...

Novo expects to file for a label expansion for Rybelsus in the United States and the European Union around the turn of the ...

In a report released today, Richard Vosser from J.P. Morgan maintained a Buy rating on Novo Nordisk (0QIU – Research Report), with a ...

Eaton Vance Worldwide Health Sciences Fund ( Trades, Portfolio) expanded its portfolio by acquiring shares in two notable ...

"We are essentially moving from a situation of defeating the enemy in all the contact villages to a state of destruction." Information ...